ClariSIGMAM

The ClariSigmam is an innovative breast cancer prediction marker. It is a breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. Quantitative breast density is the main indicator in breast cancer screening and diagnosis. The powerful pre-trained deep learning model ensures to make consistent clinical decision marking in an objective and convenient way. Novel Deep Learning Technology provides a fully automated quantification for breast and mammary area and proportion density measurements. With the world’s highest accuracy rate, ClariSigmam is convenient with a smart workflow at an affordable cost. ClariSIGMAM Benefits Precision Analysis of Breast Tissue Composition: -Precisely analyzes fat and glandular tissue composition in mammography with deep learning technology. -Achieves the world’s highest accuracy rate of 97% -Confirmed reliability in published papers Collaboration Between AI and Expert Reader: -Deep learning presents its confidence with color overlay on mammogram -Readers accept or adjust the density recommendation intuitively and conveniently -Unique color overlaid report allows easy verification of AI-predicted tissue types -Assessment available in BI-RADS 5th edition breast density category Novel Deep Learning Technology Provides: -Fully automated quantification -Breast Area/Glandular Area/Percent Density -World’s highest accuracy (97%) Product Integration and User Convenience: -Fully compliant with DICOM: Compatible with all digital mammography and PACS systems. Fully automated operation requires no separate operator -Simple Installation and fast operation via GPU computer -Compatible with multi-vendor FFDM scanners -Simplifies compliance with breast density notification laws -Convenient & smart workflow How It Works? Fully compliant with DICOM standards, ClariSIGMAM allows easy and seamless integration with digital mammography and PACS systems.